EspC promotes epithelial cell detachment by enteropathogenic Escherichia coli via sequential cleavages of a cytoskeletal protein and then focal adhesion proteins

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2255-2265

  Navarro Garcia, Fernando ^a   Serapio Palacios, Antonio ^a   Vidal, Jorge E ^a,b   Isabel Salazar, M ^a,c   Tapia Pastrana, Gabriela ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b EMORY UNIVERSITY   (United States)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOSKELETON PROTEIN; ESPC PROTEIN; FOCAL ADHESION KINASE; FODRIN; PAXILLIN; PROTEINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; ESPC PROTEIN, E COLI;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVITY; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; KINETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; BACTERIUM ADHERENCE; CELL LINE; ESCHERICHIA COLI INFECTION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

BACTERIAL ADHESION; CARRIER PROTEINS; CELL ADHESION; CELL LINE; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICROFILAMENT PROTEINS; PAXILLIN;

EID: 84900410436     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01386-13     Document Type: Article

References (50)

1. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
2. Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA. 1983. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun. 41:1340-1351.
3. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921. http://dx.doi.org/10.1046/j.1365-2958.1998.01144.x.
4. Goosney DL, DeVinney R, Pfuetzner RA, Frey EA, Strynadka NC, Finlay BB. 2000. Enteropathogenic E. coli translocated intimin receptor, Tir, interacts directly with alpha-actinin. Curr. Biol. 10:735-738. http://dx.doi.org/10.1016/S0960-9822(00)00543-1.
5. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 92:1664-1668. http://dx.doi.org/10.1073/pnas.92.5.1664.
6. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520. http://dx.doi.org/10.1016/S0092-8674(00)80437-7.
7. Elliott SJ, Krejany EO, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB. 2001. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect. Immun. 69:4027-4033. http://dx.doi.org/10.1128/IAI.69.6.4027-4033.2001.
8. McNamara BP, Koutsouris A, O'Connell CB, Nougayrede JP, Donnenberg MS, Hecht G. 2001. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107:621-629. http://dx.doi.org/10.1172/JCI11138.
9. Campellone KG, Robbins D, Leong JM. 2004. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nckindependent actin assembly. Dev. Cell 7:217-228. http://dx.doi.org/10.1016/j.devcel.2004.07.004.
10. Garmendia J, Phillips AD, Carlier MF, Chong Y, Schuller S, Marches O, Dahan S, Oswald E, Shaw RK, Knutton S, Frankel G. 2004. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol. 6:1167-1183. http://dx.doi.org/10.1111/j.1462-5822.2004.00459.x.
11. Dahan S, Wiles S, La Ragione RM, Best A, Woodward MJ, Stevens MP, Shaw RK, Chong Y, Knutton S, Phillips A, Frankel G. 2005. EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect. Immun. 73:679-686. http://dx.doi.org/10.1128/IAI.73.2.679-686.2005.
12. Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. 2004. Identification and characterization of NleA, a non-LEEencoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 51:1233-1249. http://dx.doi.org/10.1046/j.1365-2958.2003.03911.x.
13. Marches O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F, Mainil J, Rosenshine I, Sugai M, De Rycke J, Oswald E. 2003. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 50:1553-1567. http://dx.doi.org/10.1046/j.1365-2958.2003.03821.x.
14. Mundy R, Petrovska L, Smollett K, Simpson N, Wilson RK, Yu J, Tu X, Rosenshine I, Clare S, Dougan G, Frankel G. 2004. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect. Immun. 72:2288-2302. http://dx.doi.org/10.1128/IAI.72.4.2288-2302.2004.
15. Kelly M, Hart E, Mundy R, Marches O, Wiles S, Badea L, Luck S, Tauschek M, Frankel G, Robins-Browne RM, Hartland EL. 2006. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74:2328-2337. http://dx.doi.org/10.1128/IAI.74.4.2328-2337.2006.
16. Marches O, Wiles S, Dziva F, La Ragione RM, Schuller S, Best A, Phillips AD, Hartland EL, Woodward MJ, Stevens MP, Frankel G. 2005. Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect. Immun. 73:8411-8417. http://dx.doi.org/10.1128/IAI.73.12.8411-8417.2005.
17. Rothbaum RJ, Giannella RA, Partin JC. 1982. Diarrhea caused by adherent enteropathogenic E. coli. J. Pediatr. 101:486. http://dx.doi.org/10.1016/S0022-3476(82)80105-4.
18. Rothbaum RJ, Partin JC, Saalfield K, McAdams AJ. 1983. An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct. Pathol. 4:291-304. http://dx.doi.org/10.3109/01913128309140582.
19. Abreu AG, Bueris V, Porangaba TM, Sircili MP, Navarro-Garcia F, Elias WP. 2013. Autotransporter protein-encoding genes of diarrheagenic Escherichia coli are found in both typical and atypical enteropathogenic E. coli strains. Appl. Environ. Microbiol. 79:411-414. http://dx.doi.org/10.1128/AEM.02635-12.
20. Mellies JL, Navarro-Garcia F, Okeke I, Frederickson J, Nataro JP, Kaper JB. 2001. espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect. Immun. 69:315-324. http://dx.doi.org/10.1128/IAI.69.1.315-324.2001.
21. Stein M, Kenny B, Stein MA, Finlay BB. 1996. Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins. J. Bacteriol. 178:6546-6554.
22. Navarro-Garcia F, Sonnested M, Teter K. 2010. Host-Toxin Interactions Involving EspC and Pet, Two Serine Protease Autotransporters of the Enterobacteriaceae. Toxins (Basel) 2:1134-1147. http://dx.doi.org/10.3390/toxins2051134.
23. Elliott SJ, Sperandio V, Giron JA, Shin S, Mellies JL, Wainwright L, Hutcheson SW, McDaniel TK, Kaper JB. 2000. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEEand non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 68:6115-6126. http://dx.doi.org/10.1128/IAI.68.11.6115-6126.2000.
24. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33:296-306. http://dx.doi.org/10.1046/j.1365-2958.1999.01473.x.
25. Kenny B, Finlay BB. 1995. Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 92:7991-7995. http://dx.doi.org/10.1073/pnas.92.17.7991.
26. Vidal JE, Navarro-Garcia F. 2006. Efficient translocation of EspC into epithelial cells depends on enteropathogenic Escherichia coli and host cell contact. Infect. Immun. 74:2293-2303. http://dx.doi.org/10.1128/IAI.74.4.2293-2303.2006.
27. Vidal JE, Navarro-Garcia F. 2008. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell Microbiol. 10:1975-1986. http://dx.doi.org/10.1111/j.1462-5822.2008.01181.x.
28. Navarro-Garcia F, Canizalez-Roman A, Sui BQ, Nataro JP, Azamar Y. 2004. The serine protease motif of EspC from enteropathogenic Escherichia coli produces epithelial damage by a mechanism different from that of Pet toxin from enteroaggregative E. coli. Infect. Immun. 72:3609-3621. http://dx.doi.org/10.1128/IAI.72.6.3609-3621.2004.
29. Rosenshine I, Ruschkowski S, Finlay BB. 1996. Expression of attaching/effacing activity by enteropathogenic Escherichia coli depends on growth phase, temperature, and protein synthesis upon contact with epithelial cells. Infect. Immun. 64:966-973.
30. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254. http://dx.doi.org/10.1016/0003-2697(76)90527-3.
31. Canizalez-Roman A, Navarro-Garcia F. 2003. Fodrin CaM-binding domain cleavage by Pet from enteroaggregative Escherichia coli leads to actin cytoskeletal disruption. Mol. Microbiol. 48:947-958. http://dx.doi.org/10.1046/j.1365-2958.2003.03492.x.
32. Crane JK, McNamara BP, Donnenberg MS. 2001. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol. 3:197-211. http://dx.doi.org/10.1046/j.1462-5822.2001.00103.x.
33. Crane JK, Majumdar S, Pickhardt DF, III. 1999. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect. Immun. 67:2575-2584.
34. Barnett Foster D, Abul-Milh M, Huesca M, Lingwood CA. 2000. Enterohemorrhagic Escherichia coli induces apoptosis which augment bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. Infect. Immun. 68:3108-3115. http://dx.doi.org/10.1128/IAI.68.6.3108-3115.2000.
35. Abul-Milh M, Wu Y, Lau B, Lingwood CA, Barnett Foster D. 2001. Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili. Infect. Immun. 69:7356-7364. http://dx.doi.org/10.1128/IAI.69.12.7356-7364.2001.
36. Crane JK, Vezina CM. 2005. Externalization of host cell protein kinase C during enteropathogenic Escherichia coli infection. Cell Death Differ. 12: 115-127. http://dx.doi.org/10.1038/sj.cdd.4401531.
37. Flynn AN, Buret AG. 2008. Caspases-3,-8, and-9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability. Microb. Pathog. 44:311-319. http://dx.doi.org/10.1016/j.micpath.2007.10.007.
38. Fagundes-Neto U, Freymuller E, Gandolfi Schimitz L, Scaletsky I. 1996. Nutritional impact and ultrastructural intestinal alterations in severe infections due to enteropathogenic Escherichia coli strains in infants. J. Am. Coll. Nutr. 15:180-185. http://dx.doi.org/10.1080/07315724.1996.10718586.
39. Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM. 1987. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr. Infect. Dis. J. 6:829-831. http://dx.doi.org/10.1097/00006454-198709000-00008.
40. Knutton S, McConnell MM, Rowe B, McNeish AS. 1989. Adhesion and ultrastructural properties of human enterotoxigenic Escherichia coli producing colonization factor antigens III and IV. Infect. Immun. 57:3364-3371.
41. Shifrin Y, Kirschner J, Geiger B, Rosenshine I. 2002. Enteropathogenic Escherichia coli induces modification of the focal adhesions of infected host cells. Cell Microbiol. 4:235-243. http://dx.doi.org/10.1046/j.1462-5822.2002.00188.x.
42. Wang KK. 2000. Calpain and caspase: can you tell the difference? Trends Neurosci. 23:20-26. http://dx.doi.org/10.1016/S0166-2236(99)01479-4.
43. Simovitch M, Sason H, Cohen S, Zahavi EE, Melamed-Book N, Weiss A, Aroeti B, Rosenshine I. 2010. EspM inhibits pedestal formation by enterohaemorrhagic Escherichia coli and enteropathogenic E. coli and disrupts the architecture of a polarized epithelial monolayer. Cell Microbiol. 12:489-505. http://dx.doi.org/10.1111/j.1462-5822.2009.01410.x.
44. Wong AR, Raymond B, Collins JW, Crepin VF, Frankel G. 2012. The enteropathogenic E. coli effector EspH promotes actin pedestal formation and elongation via WASP-interacting protein (WIP). Cell Microbiol. 14: 1051-1070. http://dx.doi.org/10.1111/j.1462-5822.2012.01778.x.
45. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I. 2008. Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3:104-113. http://dx.doi.org/10.1016/j.chom.2007.11.007.
46. Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR, Sotman S. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are noninvasive. Lancet i:1119-1122.
47. Camguilhem R, Milon A. 1989. Biotypes and O serogroups of Escherichia coli involved in intestinal infections of weaned rabbits: clues to diagnosis of pathogenic strains. J. Clin. Microbiol. 27:743-747.
48. Jarvis KG, Giron JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. U. S. A. 92:7996-8000. http://dx.doi.org/10.1073/pnas.92.17.7996.
49. Boyer HW, Roulland-Dussoix D. 1969. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41:459-472. http://dx.doi.org/10.1016/0022-2836(69)90288-5.
50. Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS. 1997. Sitedirected mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility. Biochemistry 36:57-65. http://dx.doi.org/10.1021/bi962034i.